7Baggers
 Corvus Pharmaceuticals (CRVS) Stock Analysis Report | Financials & Insights  Benzinga España Sat, 04 Jul 2026 06:47:34 GMT
 corvus pharmaceuticals (crvs) stock analysis report | financials & insights  Benzinga España Wed, 01 Jul 2026 07:22:38 GMT
 corvus pharmaceuticals, inc. actuals & estimates (bx:c17)  TradingView Sat, 27 Jun 2026 06:06:53 GMT
 corvus pharmaceuticals, inc. actuals & estimates (swb:c17)  TradingView Fri, 26 Jun 2026 05:25:43 GMT
 CRVS Forecast — Price Target — Prediction for 2027  TradingView Thu, 25 Jun 2026 12:08:42 GMT
 corvus pharmaceuticals inc (crvs) institutional confidence  TradingKey Wed, 17 Jun 2026 22:49:33 GMT
 Insider Buys Additional US$250k In Corvus Pharmaceuticals Stock  simplywall.st Wed, 17 Jun 2026 07:00:00 GMT
 Corvus CEO thinks his next blockbuster is an ITK inhibitor  Pharma Voice Tue, 16 Jun 2026 07:00:00 GMT
 [Form 4] Corvus Pharmaceuticals, Inc. Insider Trading Activity  Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
 Corvus (CRVS) director awarded options for 15,000 shares at $11.60  Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
 Director at Corvus (CRVS) receives grant of 15,000 stock options  Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
 insider purchase: director at $crvs buys 21,700 shares  Moomoo Mon, 15 Jun 2026 07:00:00 GMT
 Is Corvus Pharmaceuticals, Inc. (CRVS) A Good Stock To Buy Now?  Yahoo Finance Sat, 13 Jun 2026 07:00:00 GMT
 corvus hikes on position in angel  Baystreet.ca Tue, 09 Jun 2026 14:06:00 GMT
 corvus pharmaceuticals | schedule 13g/a: others  Moomoo Tue, 09 Jun 2026 11:20:35 GMT
 crvs - corvus pharmaceuticals inc short interest  Finviz Thu, 28 May 2026 03:24:34 GMT
 CRVS - Corvus Pharmaceuticals Inc Stock Price and Quote  Finviz Wed, 27 May 2026 08:05:39 GMT
 corvus (crvs) ceo adds 6,932 shares via miller-horning family trust  Stock Titan Wed, 20 May 2026 07:00:00 GMT
 corvus pharmaceuticals, inc. - common stock (nq: crvs  FinancialContent Sun, 17 May 2026 07:10:15 GMT
 point72, steven a. cohen show 0% stake in corvus (crvs)  Stock Titan Fri, 15 May 2026 07:00:00 GMT
 Drug-free remissions seen after short atopic dermatitis treatment  Stock Titan Thu, 14 May 2026 07:00:00 GMT
 Corvus drops on trial data for eczema therapy (CRVS:NASDAQ)  Seeking Alpha Thu, 14 May 2026 07:00:00 GMT
 corvus pharmaceuticals : crvs sid investor meeting presentation final  marketscreener.com Thu, 14 May 2026 07:00:00 GMT
 msn money  MSN Fri, 08 May 2026 14:02:07 GMT
 corvus: q1 earnings snapshot  theheraldreview.com Fri, 08 May 2026 08:51:51 GMT
 corvus pharmaceuticals earnings up next as ad trial looms by investing.com  Investing.com Australia Fri, 08 May 2026 07:00:00 GMT
 corvus pharmaceuticals reports q1 eps (15c), consensus (15c)  TipRanks Thu, 07 May 2026 21:45:35 GMT
 Corvus Pharmaceuticals earnings up next as AD trial looms  Investing.com Thu, 07 May 2026 07:00:00 GMT
 Corvus to show eczema data backing drug-free remission potential  Stock Titan Thu, 07 May 2026 07:00:00 GMT
 cash runway to 2028 as corvus (nasdaq: crvs) advances soquelitinib  Stock Titan Thu, 07 May 2026 07:00:00 GMT
 corvus: q1 earnings snapshot  San Francisco Chronicle Thu, 07 May 2026 07:00:00 GMT
 corvus pharmaceuticals | 10-q: q1 2026 earnings report  Moomoo Thu, 07 May 2026 07:00:00 GMT
 msn money  MSN Thu, 07 May 2026 04:18:51 GMT
 msn money  MSN Wed, 06 May 2026 08:22:14 GMT
 crvs sec filings - corvus pharmaceu 10-k, 10-q, 8-k forms  Stock Titan Tue, 05 May 2026 05:13:30 GMT
 msn money  MSN Sat, 02 May 2026 16:25:18 GMT
 msn money  MSN Fri, 01 May 2026 23:13:09 GMT
 msn money  MSN Thu, 30 Apr 2026 19:34:04 GMT
 corvus pharmaceuticals (crvs) to release earnings on thursday  MarketBeat Thu, 30 Apr 2026 11:06:57 GMT
 msn money  MSN Wed, 29 Apr 2026 07:00:00 GMT
 corvus pharmaceuticals (crvs) director andrew chan files form 3  Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
 corvus pharmaceuticals | schedule 13g/a: others  Moomoo Mon, 27 Apr 2026 07:00:00 GMT

Corvus Pharmaceuticals, Inc
(NASDAQ:CRVS) 

CRVS stock logo

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-006, an anti-CD73 monoclonal antibody, which is in Phase I/Ib clinical trial that inhibits the production of aden...

Founded: 2014
Full Time Employees: 52
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends